• Corlopam (fenoldopam mesylate) Injection is a dopamine receptor agonist (vasodilator) used for in-hospital, short-term (up to 48 hours) management of severe high blood pressure ( hypertension ) when rapid, but quickly reversible, emergency reduction of blood pressure is indicated. (rxlist.com)
  • Our Corlopam (fenoldopam mesylate) Injection Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. (rxlist.com)
  • Corlopam (fenoldopam mesylate) injection, USP is a dopamine D1-like receptor agonist . (rxlist.com)
  • Benztropine mesylate is a synthetic compound containing structural features found in atropine and diphenhydramine. (nih.gov)
  • Benztropine mesylate is a crystalline white powder, very soluble in water, and has a molecular weight of 403.54. (nih.gov)
  • Each benztropine mesylate tablet USP for oral administration contains benztropine mesylate USP 0.5 mg, 1 mg or 2 mg. (nih.gov)
  • Benztropine mesylate possesses both anticholinergic and antihistaminic effects, although only the former have been established as therapeutically significant in the management of parkinsonism. (nih.gov)
  • Benztropine mesylate tablets USP are indicated for use as an adjunct in the therapy of all forms of parkinsonism. (nih.gov)
  • Hypersensitivity to benztropine mesylate tablets or to any component of the tablets. (nih.gov)
  • Benztropine mesylate may impair mental and/or physical abilities required for performance of hazardous tasks, such as operating machinery or driving a motor vehicle. (nih.gov)
  • When benztropine mesylate is given concomitantly with phenothiazines, haloperidol, or other drugs with anticholinergic or antidopaminergic activity, patients should be advised to report gastrointestinal complaints, fever or heat intolerance promptly. (nih.gov)
  • Paralytic ileus, hyperthermia and heat stroke, all of which have sometimes been fatal, have occurred in patients taking anticholinergic-type antiparkinsonism drugs, including benztropine mesylate, in combination with phenothiazines and/or tricyclic antidepressants. (nih.gov)
  • Since benztropine mesylate contains structural features of atropine, it may produce anhidrosis. (nih.gov)
  • Since benztropine mesylate has cumulative action, continued supervision is advisable. (nih.gov)
  • Urinary retention has been reported with benztropine mesylate. (nih.gov)
  • Benztropine mesylate is not recommended for use in patients with tardive dyskinesia. (nih.gov)
  • BENZTROPINE MESYLATE TABLETS USP are white coloured, circular, biconvex tablets with break line on one side and "SGP" embossed on the other side. (sgpharma.com)
  • BENZTROPINE MESYLATE TABLETS USP is recommended for all forms of parkinsonism including arteriosclerotic, postencephalitic, idiopathic, as well as medicine-induced extrapyramidal disorders (except tardive dyskinesia). (sgpharma.com)
  • BENZTROPINE MESYLATE TABLETS USP often is helpful in patients who have become unresponsive to other agents. (sgpharma.com)
  • BENZTROPINE MESYLATE TABLETS USP is a powerful anticholinergic agent which is mainly effective in relieving tremor and rigidity. (sgpharma.com)
  • Because of cumulative action of BENZTROPINE MESYLATE TABLETS USP, therapy should be initiated with a low dose which is increased gradually at five or six-day intervals to the smallest amount necessary for optimal relief. (sgpharma.com)
  • When BENZTROPINE MESYLATE TABLETS USP is started, do not terminate therapy with other antiparkinsonian agents abruptly. (sgpharma.com)
  • The phenotypic differences between dam-3 and dam+ bacteria include: (i) increased free phage in lysogenic dam-3 cultures, (2) increased sensitivity to methyl methanesulfonate (MMS), (3) inviability of dam-3 lex-I strains, (4) lower molecular weight of DNA in dam-3 bacteria in the absence of DNA ligase and (5) increased rate of DNA degradation in dam-3 recA strains. (umassmed.edu)
  • We also offer the methanesulfonate salt form of dabrafenib: Cat. (lclabs.com)
  • Related: 1218779-75-9 (Apatinib mesylate salt) 811803-05-1 (Apatinib free base). (medkoo.com)
  • The CAS number of the methanesulfonate salt form is 1195768-06-9. (lclabs.com)
  • Used (in the form of its methanesulfonate salt) as an anaesthetic for fish. (chemspider.com)
  • It is designated chemically as 3α-(Diphenylmethoxy)-1αH, 5αH-tropane methanesulfonate. (nih.gov)
  • The empirical formula of rasagiline mesylate is (C 12 H 13 N)CH 4 SO 3 and its molecular weight is 267.34. (recallguide.org)
  • Rasagiline mesylate is a white to off-white powder, freely soluble in water or ethanol and sparingly soluble in isopropanol. (recallguide.org)
  • Each AZILECT tablet for oral administration contains rasagiline mesylate equivalent to 0.5 mg or 1 mg of rasagiline base. (recallguide.org)
  • Dihydroergotamine is commonly used as the mesylate by subcutaneous, intramuscular, or intravenous injection, although it may also be given as a nasal spray or orally. (pocketdrugguide.com)
  • For the treatment of migraine and to terminate an acute attack of cluster headache, dihydroergotamine mesylate is usually given by subcutaneous or intramuscular injection in doses of 1 mg repeated, if necessary, after 30 to 60 minutes up to a maximum daily dose of 3 mg. (pocketdrugguide.com)
  • The usual nasal dose of dihydroergotamine mesylate for an acute migraine attack is 500 micrograms sprayed into each nostril as a 0.4% solution, followed after 15 minutes by an additional 500 micrograms in each nostril. (pocketdrugguide.com)
  • Doxazosin Mesylate tablet is indicated for the treatment of the signs and symptoms of BPH. (nih.gov)
  • Doxazosin Mesylate tablet is indicated for the treatment of hypertension, to lower blood pressure. (nih.gov)
  • Each XADAGO tablet contains 65.88 mg or 131.76 mg of safinamide mesylate, equivalent to 50 mg or 100 mg, respectively, of safinamide free base. (mdtodate.com)
  • Although results of such therapy have not been published, conversations by CDC with Canadian physicians concerning the outcomes of 13 AIDS patients with PCP treated with pentamidine methanesulfonate indicate that the efficacy and toxicity of the methanesulfonate salt appear similar to those of the isethionate salt. (cdc.gov)
  • 3. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity. (nih.gov)
  • 8. Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate. (nih.gov)
  • Safinamide mesylate is freely soluble in water, methanol and dimethyl sulfoxide. (mdtodate.com)
  • Concomitant administration of Doxazosin Mesylate with a phosphodiesterase-5 (PDE-5) inhibitor can result in additive blood pressure lowering effects and symptomatic hypotension. (nih.gov)
  • WebImatinib mesylate is a small molecule protein tyrosine kinase inhibitor that inhibits the Bcr-Abl tyrosine kinase, the constitutive abnormal tyrosine kinase created by the Philadelphia chromosome abnormality in chronic myeloid leukemia (CML). (urlbacklinks.com)
  • FOY: [Ethyl p-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. (bio-techne.com)
  • XADAGO tablets contain safinamide, which is a MAO-B inhibitor, as the mesylate salt. (mdtodate.com)
  • Hydergine is a mixture of the methanesulfonate salts of three hydrogenated alkaloids, dihydroergocristine, dihydroergocornine, and dihydroergocryptine in an approximate weight ratio of 1:1:1. (nih.gov)
  • These highlights do not include all the information needed to use Doxazosin Mesylate safely and effectively. (nih.gov)
  • See full prescribing information for Doxazosin Mesylate. (nih.gov)
  • Hypersensitivity to doxazosin, other quinazolines, or any other ingredient in Doxazosin Mesylate. (nih.gov)
  • WebDoxazosin MESYLATE - Uses, Side Effects, and More Common Brand (S): Cardura Uses Doxazosin is used alone or with other drugs to treat high blood pressure (hypertension). (urlbacklinks.com)
  • GEODON is available as capsules (ziprasidone hydrochloride) for oral administration and as an injection (ziprasidone mesylate) for intramuscular use only. (rxlist.com)
  • Geodon (ziprasidone HCl) is available as capsules and Geodon (ziprasidone mesylate) is available as an injection for intramuscular use. (rxlist.com)
  • The molecular formula of safinamide mesylate is C 17 H 19 FN 2 O 2 ∙CH 4 O 3 S and its molecular weight is 398.45. (mdtodate.com)
  • Each ampule of pentamidine methanesulfonate solution contains the equivalent of 120 mg of pentamidine base dissolved in 3.0 ml of sterile water for injection. (cdc.gov)
  • Ergoloid Mesylate may increase cerebral metabolism and blood flow. (pharmacycode.com)
  • Expressed in terms of volume, the dose of pentamidine methanesulfonate is 0.0575 ml/kg. (cdc.gov)
  • One published report has suggested that hypoglycemia occurs more commonly with pentamidine methanesulfonate than with pentamidine isethionate, but the number of patients described was small (1). (cdc.gov)
  • WebNotice, though, that unlike the halogenation reactions above, conversion of an alcohol to a tosylate or mesylate proceeds with retention of configuration at the electrophilic carbon. (urlbacklinks.com)
  • 13. Trace determination of ethyl methanesulfonate in Viracept 250 mg tablets by gas chromatography-mass spectrometry. (nih.gov)
  • AZILECT® tablets contain rasagiline (as the mesylate), a propargylamine-based drug indicated for the treatment of idiopathic Parkinson's disease. (recallguide.org)
  • Safinamide mesylate is a white to off-white crystalline powder. (mdtodate.com)
  • 2. The Viracept (nelfinavir)--ethyl methanesulfonate case: a threshold risk assessment for human exposure to a genotoxic drug contamination? (nih.gov)
  • Geodon (ziprasidone HCl and ziprasidone mesylate) is an atypical antipsychotic used to treat symptoms of schizophrenia and acute manic or mixed episodes associated with bipolar disorder . (rxlist.com)
  • En outre, l'invention concerne des compositions comprenant un inhibiteur de 17.alpha. (gc.ca)
  • This graph shows the total number of publications written about "Mesylates" by people in Harvard Catalyst Profiles by year, and whether "Mesylates" was a major or minor topic of these publication. (harvard.edu)
  • Below are the most recent publications written about "Mesylates" by people in Profiles. (harvard.edu)
  • Physicians in France and Canada have used pentamidine methanesulfonate to treat AIDS patients with PCP. (cdc.gov)
  • acétoxy-17-(3-pyridyl)androsta-5,16-diène), en association avec au moins un agent thérapeutique supplémentaire tel qu'un agent anticancéreux ou un stéroïde. (gc.ca)
  • Gleevec (imatinib mesylate, STI-571) is the first targeted anti-cancer agent which was developed by Norvartis and released in 2002. (justia.com)